Results 1 to 10 of about 16,566,551 (307)

Micronutrient fortification to improve growth and health of maternally HIV-unexposed and exposed Zambian infants: a randomised controlled trial. [PDF]

PLoS ONE, 2010
BackgroundThe period of complementary feeding, starting around 6 months of age, is a time of high risk for growth faltering and morbidity. Low micronutrient density of locally available foods is a common problem in low income countries.
Chilenje Infant Growth, Nutrition and Infection (CIGNIS) Study Team
doaj   +3 more sources

Medical cannabis authorization patterns, safety, and associated effects in older adults

Journal of Cannabis Research, 2022
Background Use of medical cannabis is increasing among older adults. However, few investigations have examined cannabis use in this population. Methods We assessed the authorization patterns, safety, and effects of medical cannabis in a sub-analysis of ...
Laura MacNair, Maja Kalaba, Erica N. Peters, Matthew T. Feldner, Graham M. L. Eglit, Lucile Rapin, Cynthia El Hage, Erin Prosk, Mark A. Ware   +8 more
doaj   +1 more source

Longitudinal Relationship between the Introduction of Medicinal Cannabis and Polypharmacy: An Australian Real-World Evidence Study

International Journal of Clinical Practice, 2022
Background. Recent studies recommend medicinal cannabis (MC) as a potential treatment for chronic pain (CP) when conventional therapies are not successful; however, data from Australia is limited.
Maja Kalaba, Graham M. L. Eglit, Matthew T. Feldner, Patrizia D. Washer, Tracie Ernenwein, Alistair W. Vickery, Mark A. Ware   +6 more
doaj   +1 more source

Prevalence of postural musculoskeletal symptoms among dental students in United Arab Emirates

BMC Musculoskeletal Disorders, 2021
Background The purpose of the present study was to determine the prevalence of neck, shoulder, and low-back pain and to examine factors associated with musculoskeletal pain (MSP) among dental students at Ajman University and Ras Al Khaimah College of ...
Raghad Hashim, Afraa Salah, Fatemeh Mayahi, Saeedeh Haidary   +3 more
doaj   +1 more source

Which Groups of Children Are at More Risk of Fatality during COVID-19 Pandemic? A Case-Control Study in Yazd, Iran

Canadian Journal of Infectious Diseases and Medical Microbiology, 2023
Introduction. The study aims to investigate the characteristics, comorbidities, laboratory findings, and clinical manifestations of under 18-year-old patients who died with the diagnosis of COVID-19 and determination of the most prevalent risk factors ...
Behnam Shafaei, Zahra Nafei, Mehran Karimi, Nasrin Behniafard, Farimah Shamsi, Masoud Faisal, Amir Pasha Amel Shahbaz, Elahe Akbarian   +7 more
doaj   +1 more source

Survival and Mortality in Hospitalized Children with COVID-19: A Referral Center Experience in Yazd, Iran

Canadian Journal of Infectious Diseases and Medical Microbiology, 2023
Introduction. COVID-19 prognostic risk factors, therapeutic protocols, and clinical outcomes in pediatric cases are still under investigation. Materials and Methods.
Farimah Shamsi, Mehran Karimi, Zahra Nafei, Elahe Akbarian   +3 more
doaj   +1 more source

Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial

Orphanet Journal of Rare Diseases, 2016
Background Patients with Prader-Willi syndrome (PWS) have a cognitive impairment. Growth hormone (GH) treatment during childhood improves cognitive functioning, while cognition deteriorates in GH-untreated children with PWS.
R. J. Kuppens, E. F. Mahabier, N. E. Bakker, E. P. C. Siemensma, S. H. Donze, A. C. S. Hokken-Koelega   +5 more
doaj   +1 more source

Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition

Orphanet Journal of Rare Diseases, 2020
Background In children with Prader-Willi syndrome (PWS), the benefits of growth hormone treatment are well established. Several one-year studies have shown that growth hormone is also beneficial for adults with PWS, improving body composition.
Layla Damen, Stephany H. Donze, Renske J. Kuppens, Nienke E. Bakker, Laura C. G. de Graaff, Janielle A. E. M. van der Velden, Anita C. S. Hokken-Koelega   +6 more
doaj   +1 more source

UGT2B17 genotype and the pharmacokinetic serum profile of Testosterone during substitution therapy with Testosterone Undecanoate. A retrospective experience from 207 men with hypogonadism.

Frontiers in Endocrinology, 2013
BackgroundTestosterone (T) is mainly excreted in the urine as testosterone glucuronide (TG). This glucuronidation is partly dependent on the UGT2B17 genotype, and TG excretion is therefore lower in men having the UGT2B17 deletion.
Anne Kirstine eBang, Niels eJørgensen, Ewa eRajpert-De Meyts, Anders eJuul   +3 more
doaj   +1 more source

Effects of human recombinant growth hormone on exercise capacity, cardiac structure, and cardiac function in patients with adult-onset growth hormone deficiency [PDF]

, 2017
Objective Epidemiological studies suggest that adult-onset growth hormone deficiency (AGHD) might increase the risk of death from cardiovascular causes. Methods This was a 6-month double-blind, placebo-controlled, randomised, cross-over trial followed by
Atkin, S. L., Atkin, Stephen, Clark, AL, Clark, Andrew, Gonzalez, S., Gonzalez, Susana, Javed, Z., Javed, Zeeshan, Sathyapalan, T., Sathyapalan, Thozhukat, Windram, Hull, Windram, J. D.   +11 more
core   +1 more source